ResearcherRMIT UniversityActive in the last 2 years

Vasso Apostolopoulos

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6788-2771; OpenAlex author ID A5051380014. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2024: 1 paper · 2025: none · 2026: 1 paper

Papers 2

Pyridoxal 5'-Phosphate Suppresses Growth of Pancreatic Adenocarcinoma Cells In Vitro via Regulation of Oncogenic RAS. Last author DOI 10.1002/mnfr.70333 ↗
A new era of immune therapeutics for pancreatic cancer: Monoclonal antibodies paving the way. First author DOI 10.1016/j.ejphar.2024.176451 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Pankti C. Balar · 1 shared paper, 2024 · strength 0.36
- Paper A new era of immune therapeutics for pancreatic cancer: Monoclonal antibodies paving the way. DOI 10.1016/j.ejphar.2024.176451 ↗
Vivek P. Chavda · 1 shared paper, 2024 · strength 0.36
- Paper A new era of immune therapeutics for pancreatic cancer: Monoclonal antibodies paving the way. DOI 10.1016/j.ejphar.2024.176451 ↗
Jack Feehan · 1 shared paper, 2026 · strength 0.36
- Paper Pyridoxal 5'-Phosphate Suppresses Growth of Pancreatic Adenocarcinoma Cells In Vitro via Regulation of Oncogenic RAS. DOI 10.1002/mnfr.70333 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.